AquaOmega
Natural health product licensed in Canada
- Other names
- AquaOmega Enteric Coated Softgel
- Licence holder
- Vita Naturals Inc.
- NPN or DIN-HM
- 80093002
- Status
- Active licence
- Licence date
- 24 June 2019
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 300 mg Docosahexaenoic acid | 1,200 mg | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 600 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 600 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 600 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 134 mg AT | Not calculated |
| Vitamine D Source : Cholécalciférol | 10 mcg | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 200 UI | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 300 mg Docosahexaenoic acid | 1,200 mg | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 300 mg Docosahexaenoic acid | 1,200 mg | Not calculated |
Non-medicinal ingredients
Copolymère d'acide méthacrylique, Glycérine, Propylène glycol, Eau purifiée, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 10 years ; maximum: 13 years | 1 Capsule | 1 Tous les jours |
| Adultes et adolescents | minimum: 13 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Helps support cognitive health and/or brain function. Helps support (healthy) development of brain/(and), eyes/(and) nerves in children up to 12 years of age. Helps maintain/support cardiovascular health. A factor in the maintenance of good health. Helps in the development and maintenance of bones. Helps in the development and maintenance of teeth. Helps in the absorption and use of calcium. Helps in the absorption and use of phosphorus. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis. Helps to prevent vitamin E deficiency. Vitamin E is an antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80093002
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.